{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:27:00Z","timestamp":1761514020886,"version":"3.37.3"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T00:00:00Z","timestamp":1496620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T00:00:00Z","timestamp":1496620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"UCB Nordic A\/S"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ane.12776","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T03:44:45Z","timestamp":1496720685000},"page":"521-527","source":"Crossref","is-referenced-by-count":14,"title":["Patterns of antiepileptic drug prescription in Sweden: A\u00a0register-based approach"],"prefix":"10.1155","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1682-295X","authenticated-orcid":false,"given":"K.","family":"Bolin","sequence":"first","affiliation":[{"name":"Department of Economics; University of Gothenburg; Gothenburg Sweden"},{"name":"Centre for Health Economics; University of Gothenburg; Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Berggren","sequence":"additional","affiliation":[{"name":"UCB Pharma; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Berling","sequence":"additional","affiliation":[{"name":"UCB Pharma; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morberg","sequence":"additional","affiliation":[{"name":"UCB Pharma; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gauffin","sequence":"additional","affiliation":[{"name":"Department of Neurology; Department of Clinical and Experimental Medicine; Link\u00f6ping University; Link\u00f6ping Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-M.","family":"Landtblom","sequence":"additional","affiliation":[{"name":"Department of Neurology; Department of Clinical and Experimental Medicine; Link\u00f6ping University; Link\u00f6ping Sweden"},{"name":"Department of Neuroscience\/Neurology; University of Uppsala; Uppsala Sweden"},{"name":"Department of Medical Specialist; Department of Clinical and Experimental Medicine; Link\u00f6ping University; Motala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,5]]},"reference":[{"key":"10.1111\/ane.12776-BIB0001|ane12776-cit-0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2013.11.016","article-title":"Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?","volume":"31","author":"Brodie","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12776-BIB0002|ane12776-cit-0002","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1528-1157.1993.tb02126.x","article-title":"Some aspects of prognosis in the epilepsies: a review","volume":"34","author":"Sander","year":"1993","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12776-BIB0003|ane12776-cit-0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2009.02.030","article-title":"Drug treatment of epilepsy: options and limitations","volume":"15","author":"Schmidt","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12776-BIB0004|ane12776-cit-0004","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"key":"10.1111\/ane.12776-BIB0005|ane12776-cit-0005","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.seizure.2010.07.017","article-title":"Drug treatment failures and effectivity in children with newly diagnosed epilepsy","volume":"19","author":"Arhan","year":"2010","journal-title":"Seizure"},{"key":"10.1111\/ane.12776-BIB0006|ane12776-cit-0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1111\/ane.12776-BIB0007|ane12776-cit-0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ane.12297","article-title":"Prevalence and cost of epilepsy in Sweden - a register-based approach","volume":"131","author":"Bolin","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12776-BIB0008|ane12776-cit-0008","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure at age 6\u00a0years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12776-BIB0009|ane12776-cit-0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12776-BIB0010|ane12776-cit-0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6\u00a0years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"key":"10.1111\/ane.12776-BIB0011|ane12776-cit-0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.seizure.2008.11.009","article-title":"Medical outcome in epilepsy patients of young adulthood - A 5-year follow-up study","volume":"18","author":"Gauffin","year":"2009","journal-title":"Seizure"},{"key":"10.1111\/ane.12776-BIB0012|ane12776-cit-0012","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp.71.5.632","article-title":"The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14\u00a0years","volume":"71","author":"Lhatoo","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12776-BIB0013|ane12776-cit-0013","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12776-BIB0014|ane12776-cit-0014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10198-011-0361-8","article-title":"Epilepsy in Sweden: healthcare costs and loss of productivity - a register-based approach","volume":"13","author":"Bolin","year":"2012","journal-title":"Eur J Health Econ"},{"key":"10.1111\/ane.12776-BIB0015|ane12776-cit-0015","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eplepsyres.2014.03.004","article-title":"Drug treatment in patients with newly diagnosed unprovoked seizures\/epilepsy","volume":"108","author":"Karlsson","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12776-BIB0016|ane12776-cit-0016","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12776-BIB0017|ane12776-cit-0017","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.yebeh.2010.01.167","article-title":"Self-esteem and sense of coherence in young people with uncomplicated epilepsy","volume":"17","author":"Gauffin","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12776-BIB0018|ane12776-cit-0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000112859","article-title":"The Tasmanian epilepsy register - a community based cohort. Background and methodology for patient recruitment from the Australian prescription data base","volume":"29","author":"D\u2032Souza","year":"2007","journal-title":"Neuroepidemiology."},{"key":"10.1111\/ane.12776-BIB0019|ane12776-cit-0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijcp.12182","article-title":"Pregabalin is increasingly prescribed for neuropathic pain, generalized anxiety disorders","volume":"68","author":"Wettermark","year":"2014","journal-title":"Int J Clin Pract"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12776","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12776\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:50:25Z","timestamp":1671540625000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12776","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"type":"print","value":"0001-6314"}],"subject":[],"published":{"date-parts":[[2017,6,5]]}}}